Efficacy of the GMZ2 malaria vaccine in African children

被引:0
|
作者
Milligan, Paul [1 ]
Flach, Clare [1 ]
Theisen, Michael [2 ,3 ,4 ]
机构
[1] London Sch Hyg & Trop Med, London, England
[2] Statens Serum Inst, Dept Congenital Disorders, Artillerivej 5, DK-2300 Copenhagen S, Denmark
[3] Univ Copenhagen, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, DK-1168 Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Dept Infect Dis, Rigshosp, Copenhagen, Denmark
基金
英国医学研究理事会;
关键词
D O I
10.1016/j.vaccine.2016.11.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:202 / 202
页数:1
相关论文
共 50 条
  • [1] A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
    Sirima, Sodiomon B.
    Mordmueller, Benjamin
    Milligan, Paul
    Ngoa, Ulysse Ateba
    Kironde, Fred
    Atuguba, Frank
    Tiono, Alfred B.
    Issifou, Saadou
    Kaddumukasa, Mark
    Bangre, Oscar
    Flach, Clare
    Christiansen, Michael
    Bang, Peter
    Chilengi, Roma
    Jepsen, Soren
    Kremsner, Peter G.
    Theisen, Michael
    VACCINE, 2016, 34 (38) : 4536 - 4542
  • [2] The GMZ2 malaria vaccine: from concept to efficacy in humans
    Theisen, Michael
    Adu, Bright
    Mordmueller, Benjamin
    Singh, Subhash
    EXPERT REVIEW OF VACCINES, 2017, 16 (09) : 907 - 917
  • [3] A Randomized Controlled Phase Ib Trial of the Malaria Vaccine Candidate GMZ2 in African Children
    Belard, Sabine
    Issifou, Saadou
    Hounkpatin, Aurore B.
    Schaumburg, Frieder
    Ngoa, Ulysse Ateba
    Esen, Meral
    Fendel, Rolf
    de Salazar, Pablo Martinez
    Muerbeth, Raymund E.
    Milligan, Paul
    Imbault, Nathalie
    Imoukhuede, Egeruan Babatunde
    Theisen, Michael
    Jepsen, Soren
    Noor, Ramadhani A.
    Okech, Brenda
    Kremsner, Peter G.
    Mordmueller, Benjamin
    PLOS ONE, 2011, 6 (07):
  • [4] A randomised controlled phase Ib trial of the malaria vaccine candidate GMZ2 in African children
    Hounkpatin, L. A. B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 45 - 46
  • [6] Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine
    Dassah, Sylvester
    Adu, Bright
    Sirima, Sodiomon B.
    Mordmueller, Benjamin
    Ngoa, Ulysse Ateba
    Atuguba, Frank
    Arthur, Fareed K. N.
    Mensah, Benedicta A.
    Kaddumukasa, Mark
    Bang, Peter
    Kremsner, Peter G.
    Mategula, Donnie
    Flach, Clare
    Milligan, Paul
    Theisen, Michael
    VACCINE, 2021, 39 (31) : 4314 - 4319
  • [7] Malaria vaccine GMZ2 pre-clinical selection and clinical development
    Theisen, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2010, 15 (08) : S15 - S16
  • [8] GMZ2 Vaccine-Induced Antibody Responses, Naturally Acquired Immunity and the Incidence of Malaria in Burkinabe Children
    Dassah, Sylvester
    Adu, Bright
    Tiendrebeogo, Regis W.
    Singh, Susheel K.
    Arthur, Fareed K. N.
    Sirima, Sodiomon B.
    Theisen, Michael
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Prospective study of the incidence of clinical malaria in the malaria vaccine candidate GMZ2 future trial site
    Kangoye, T. D.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 45 - 45
  • [10] Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2
    Nouatin, Odilon
    Mengue, Juliana Boex
    Dejon-Agobe, Jean Claude
    Fendel, Rolf
    Ibanez, Javier
    Ngoa, Ulysse Ateba
    Edoa, Jean Ronald
    Adegbite, Bayode Romeo
    Honkpehedji, Yabo Josiane
    Zinsou, Jeannot Frejus
    Hounkpatin, Aurore Bouyoukou
    Moutairou, Kabirou
    Homoet, Andreas
    Esen, Meral
    Kreidenweiss, Andrea
    Hoffman, Stephen L.
    Theisen, Michael
    Luty, Adrian J. F.
    Lell, Bertrand
    Agnandji, Selidji Todagbe
    Mombo-Ngoma, Ghyslain
    Ramharter, Michael
    Kremsner, Peter
    Mordmueller, Benjamin
    Adegnika, Ayola Akim
    PLOS NEGLECTED TROPICAL DISEASES, 2021, 15 (06):